2025-04

Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5/5‑HT2AR Antagonist (VVZ‑2471) in a Randomized, Double‑Blind, First‑in‑Human Study

Sungyeun Bae, HyunJoon Lee, Inkyung Song, Jina Kim, Sang Rim Lee, Sunyoung Cho, Kyung-Sang Yu, Jae-Yong Chung

CNS Drugs2025,Apr;doi: 10.1007/s40263-025-01181-9. Online ahead of print.

2025-04

Modulating the PD-1-FABP5 axis in ILC2s to regulate adipose tissue metabolism in obesity

Jongho Ham, Jaemoon Koh, Jungeun Kim, Joo-Youn Cho, TaeSoo Kim, Doo Hyun Chung, Yong-Soo Bae, Hye Young Kim

Mol Ther2025,Apr;33(4):1842-1859. doi: 10.1016/j.ymthe.2025.02.015. Epub 2025 Feb 12.

2025-04

Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients with Multiple Infections

Yoonjin Kim, Sungyeun Bae, Ki Young Huh, Jong Sun Joo, Jikyo Lee, Sang Hoon Song, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh

Ther Drug Monit2025,Apr;47(2):303-308. doi: 10.1097/FTD.0000000000001241. Epub 2024 Jul 16.

2025-03

Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation

Kyung Taek Hong, Sungyeun Bae, Yoon Sunwoo, Juyeon Lee, Hyun Jin Park, Bo Kyung Kim, Jung Yoon Choi, Joo-Youn Cho, Kyung-Sang Yu, Jaeseong Oh, Hyoung Jin Kang

Biomark Res2025,Mar;13(1):48. doi: 10.1186/s40364-025-00749-3.